Nuzenio

Stock Titan Vistagen

Stock Titan Vistagen entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 8 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Timeline

Thu, 06 Aug 2026 12:30:00 GMTVistagen's second fasedienol dose showed no new safety findings - Stock Titan
Wed, 05 Aug 2026 20:05:55 GMTVistagen Therapeutics (NASDAQ: VTGN) granted 180-day Nasdaq bid-price extension - Stock Titan
Tue, 04 Aug 2026 09:26:51 GMTL3Harris Keeps ~40% Stake in New Rocketdyne Business After Sale - Stock Titan
Fri, 31 Jul 2026 12:49:06 GMTVistagen Therapeutics (Nasdaq: VTGN) names Douglas J. Williamson to board - Stock Titan
Fri, 31 Jul 2026 12:30:00 GMTVistagen adds board director with nearly three decades in neuroscience drug development - Stock Titan
Thu, 30 Jul 2026 20:05:00 GMTIdentiv Will Skip Q2 Earnings Call Amid Pending Trackonomy Sale - Stock Titan

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Stock Titan Vistagen.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.